MSL8, [Met256]-OVA (257-264) is a modified ovalbumin epitope containing a Met substitution affecting anchor positioning in MHC complexes. Its sequence supports binding-affinity comparison with canonical OVA peptides. Researchers employ it to study epitope stability and T-cell recognition. The peptide aids mechanistic immunology.
CAT No: O05006
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.